The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine
Yıl: 2018 Cilt: 55 Sayı: 2 Sayfa Aralığı: 140 - 145 Metin Dili: İngilizce DOI: 10.5152/npa.2016.12691 İndeks Tarihi: 26-09-2019
The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine
Öz: Introduction: The aim of the present study was to assess the impact offibromyalgia (FM) comorbidity on disability, anxiety, depression, sleepdisturbance, and quality of life in patients with migraine.Methods: Eighty-six consecutive migraine patients (age, 35.4±10.3years; 69 women and 17 men) were enrolled in the study. The headachecharacteristics of the patients were recorded. FM was diagnosed basedon the 1990 American College of Rheumatology classification criteriafor the diagnosis of FM. All patients were asked to complete selfreportquestionnaires, including the Fibromyalgia Impact Questionnaire(FIQ), Headache Impact Test (HIT-6), Migraine Disability AssessmentQuestionnaire (MIDAS), Pittsburgh Sleep Quality Index (PSQI), BeckDepression Inventory (BDI), Beck Anxiety Inventory (BAI), and the 36-Item Short Form Survey (SF-36) to assess their pain-related disability,migraine-related disability, depression, anxiety, sleep disturbance, andquality of life.Results: Of the migraine patients, 28 (32.6%) met the criteria for FM.Migraine patients with FM showed significantly increased migrainefrequency and BDI, BAI, and PSQI scores and decreased quality of lifescores for all eight domains of the SF-36 compared to patients withmigraine alone, whereas the mean HIT-6 and MIDAS values did notdiffer between the groups. FIQ score showed statistically significantpositive correlations with BDI, BAI, PSQI, and MIDAS scores and withheadache frequency (p<0.001, r=0.657; p<0.001, r=0.730; p<0.001,r=0.754; p=0.005, r=0.300; p=0.008, r=0.286, respectively); FIQ scoreshowed negative correlations with scores for all domains of the SF36.In multivariate linear regression analysis, BDI, BAI, and PSQI scoresindependently predicted FIQ score.Conclusion: Our study results demonstrate the significant impact of FMcomorbidity on anxiety, depression, sleep disturbance, and quality of lifein this population. FM evaluation and treatment should be consideredin the routine care of patients with migraine to globally improve thepatient’s quality of life.
Anahtar Kelime: Konular:
Fibromiyaljinin Migrenli Hastalarda Dizabilite, Anksiyete, Depresyon, Uyku Bozukluğu ve Yaşam Kalitesi Üzerine Etkisi
Öz: Amaç: Sunulan bu çalışmanın amacı migrenli hastalarda fibromiyalji (FM) birlikteliğinin dizabilite, anksiyete, depresyon, yaşam kalitesi ve uyku bozukluğu üzerindeki etkilerini değerlendirmek idi. Yöntem: Seksenaltı ardışık migren hastası çalışmaya dahil edildi. Hastaların migren baş ağrısı karakteristikleri kaydedildi. FM tanısı 1990 Amerikan Romatizma Cemiyeti’nin FM tanı kriterlerine göre koyuldu. Ağrı ve migren ile ilişkili dizabilite, depresyon, anksiyete, uyku bozukluğu ve yaşam kalitesi tespiti için tüm hastaların Migren Dizabilite Değerlendirme Ölçeği (MDDÖ), Fibromiyalji Etki Sorgulaması (FES), Baş Ağrısı Etki Testi-6 (BET-6), Pittsburgh Uyku Kalite Indeksi (PUKİ), Beck Depresyon Envanteri (BDE), Beck Anksiyete Envanteri (BAE) ve Kısa Form 36’yı (KF-36) içeren hasta bildirimli sorgulama formlarını tamamlamaları istendi. Bulgular: Migren hastalarının 28’i (%32,6) FM tanı kriterlerini karşıladı. Ortalama BET-6 ve MDDÖ değerleri gruplar arasında farklı değilken, migrenle birlikte FM’ye sahip olan hastalar yalnızca migrene sahip olan hastalara göre artmış baş ağrısı sıklığı ve artmış BDE, BAE, PUKİ ve MDDÖ skorları ve KF-36’nın tüm alt grupları için azalmış yaşam kalitesi skorları gösterdiler. FES skorları BDE, BAE, PUKİ, MDDÖ skorları ve baş ağrısı sıklığı ile istatiksel olarak anlamlı pozitif korelasyon (p<0,001, r=0,657; p<0,001, r=0,730; p<0,001, r=0,754; p=0,005, r=0,300; p=0,008, r=0,286, sırasıyla) ve KF-36’nın tüm alt grupları ile negatif korelasyon gösterdi. Çok değişkenli lineer regresyon analizinde BDE, BAE ve PUKİ skorları FES skorlarını bağımsız şekilde tespit etti. Sonuç: Çalışmamızın sonuçları migrenli hastalarda FM birlikteliğinin anksiyete, depresyon, uyku bozukluğu ve yaşam kalitesi üzerindeki önemli etkilerini açığa çıkardı. Hastaların yaşam kalitesinde tümüyle iyileşme sağlamak için, FM incelemesi ve tedavisi migrenli hastaların rutin takibinde dikkate alınmalıdır.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28. [CrossRef]
- de Tommaso M. Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches. Expert Rev Neurother 2012;12:287-295. [CrossRef]
- Hughes G, Martinez C, Myon E, Taïeb C, Wessely S. The impact of a diagnosis of fibromyalgia on health care resource use by primary care patients in the UK: an observational study based on clinical practice. Arthritis Rheum 2006;54:177-183. [CrossRef]
- Mas AJ, Carmona L, Valverde M, Ribas B; EPISER Study Group. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 2008;26:519-526.
- Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210. [CrossRef]
- Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep 2012;16:86-92. [CrossRef]
- Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol 2005;18:305-310. [CrossRef]
- Hagen K, Einarsen C, Zwart JA, Svebak S, Bovim G. The co-occurrence of headache and musculoskeletal symptoms amongst 51050 adults in Norway. Eur J Neurol 2002;9:527-533. [CrossRef]
- Centonze V, Bassi A, Cassiano MA, Munno I, Dalfino L, Causarano V. Migraine, daily chronic headache and fibromyalgia in the same patient: an evolutive “continuum” of non organic chronic pain? About 100 clinical cases. Neurol Sci 2004;25:291-292. [CrossRef]
- Moskowitz MA. Basic mechanisms in vascular headache. Neurol Clin 1990;8:801-815.
- Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-624. [CrossRef]
- Buchgreitz L, Lyngberg AC, Bendtsen L, Jensen R. Frequency of headache is related to sensitization: a population study. Pain 2006;123:19-27. [CrossRef]
- Marcus DA, Bernstein C, Rudy TE. Fibromyalgia and headache: an epidemiological study supporting migraine as part of thefibromyalgia syndrome. Clin Rheumatol 2005;4:595-601. [CrossRef]
- Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 2006;26:451-456. [CrossRef]
- de Tommaso M, Sardaro M, Serpino C, Costantini F, Vecchio E, Prudenzano MP, Lamberti P, Livrea P. Fibromyalgia comorbidity in primary headaches. Cephalalgia 2009;9:453-464. [CrossRef]
- Evans RW, de Tommaso M. Migraine and fibromyalgia. Headache 2011;51:295- 299. [CrossRef]
- Wang SJ, Chen PK, Fuh JL. Comorbidities of Migraine. Front Neurol 2010;1:16. [CrossRef]
- Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24:9-160.
- Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172. [CrossRef]
- Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12:963-974. [CrossRef]
- Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headacherelated disability. Neurology 2001;56(Suppl 1):20-28.
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. [CrossRef]
- Hisli N. A study on validity and reliability test of the Beck Depression Scale. Journal of Psychology 1988;6:118-122.
- Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 2011;63(Suppl 11):467-472.
- Ulusoy M, Sahin NH, Erkmen H. Turkish version of the beck anxiety inventory: psychometric properties. J Cogn Psychother 1998;12:163-172.
- Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213. [CrossRef]
- Ağargün MY, Kara H, Anlar O. The validity and reliability of the Pittsburgh Sleep Quality Index. Turk Psikiyatri Derg 1996; 7:107-111.
- Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF36). I. Conceptual framework and item selection. Med Care 1992;30:473- 483.
- Demiral Y, Ergor G, Unal B, Semin S, Akvardar Y, Kıvırcık B, Alptekin K. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health 2006;6:247. [CrossRef]
- Burckhardt, CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: Development and validation. J Rheumatol 1991;18:728-734.
- Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int 2000;20:9-12. [CrossRef]
- Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G. The prevalence of fibromyalgia in women aged 20-64 in Turkey. Scand J Rheumatol 2005;34:140- 144.
- Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 2010;39:448-453. [CrossRef]
- Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A, Herial NA, Utley C, White L, Khuder SA. Allodynia in migraine: association with comorbid pain conditions. Headache 2009;49:1333-1344. [CrossRef]
- Küçükşen S, Genç E, Yılmaz H, Sallı A, Gezer İA, Karahan AY, Salbaş E, Cingöz HT, Nas Ö, Uğurlu H. The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 2013;32:983- 990. [CrossRef]
- Vij B, Whipple MO, Tepper SJ, Mohabbat AB, Stillman M, Vincent A. Frequency of Migraine Headaches in Patients With Fibromyalgia. Headache 2015;55:860-865. [CrossRef]
- Marcus DA, Bhowmick A. Fibromyalgia comorbidity in a community sample of adults with migraine. Clin Rheumatol 2013;32:1553-1556. [CrossRef]
- Buse DC, Silberstein SD, Manack AN, Papapetropoulos S, Lipton RB. Psychiatric comorbidities of episodic and chronic migraine. J Neurol 2013;260:1960- 1969. [CrossRef]
- Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache 2006;46:1344-1363. [CrossRef]
- Walters AB, Hamer JD, Smitherman TA. Sleep disturbance and affective comorbidity among episodic migraineurs. Headache 2014;54:116-124. [CrossRef]
- de Tommaso M, Federici A, Serpino C, Vecchio E, Franco G, Sardaro M, Delussi M, Livrea P. Clinical features of headache patients with fibromyalgia comorbidity. J Headache Pain 2011;12:629-638. [CrossRef]
- Mongini F, Deregibus A, Rota E. Psychiatric disorders and muscle tenderness in episodic and chronic migraine. Expert Rev Neurother 2005;5:635-642. [CrossRef]
- Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: a comparative analysis. J Rheumatol 1993;20:475-479.
- Salaffi F, Sarzi-Puttini P, Girolimetti R, Atzeni F, Gasparini S, Grassi W. Healthrelated quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey. Clin Exp Rheumatol 2009;27(Suppl 56):67-74.
| APA | SERDAROĞLU BEYAZAL M, TÜFEKÇİ A, KIRBAŞ S, TOPALOĞLU M (2018). The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. , 140 - 145. 10.5152/npa.2016.12691 |
| Chicago | SERDAROĞLU BEYAZAL Münevver,TÜFEKÇİ AHMET,KIRBAŞ Serkan,TOPALOĞLU MEHMET SERHAT The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. (2018): 140 - 145. 10.5152/npa.2016.12691 |
| MLA | SERDAROĞLU BEYAZAL Münevver,TÜFEKÇİ AHMET,KIRBAŞ Serkan,TOPALOĞLU MEHMET SERHAT The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. , 2018, ss.140 - 145. 10.5152/npa.2016.12691 |
| AMA | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. . 2018; 140 - 145. 10.5152/npa.2016.12691 |
| Vancouver | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. . 2018; 140 - 145. 10.5152/npa.2016.12691 |
| IEEE | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M "The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine." , ss.140 - 145, 2018. 10.5152/npa.2016.12691 |
| ISNAD | SERDAROĞLU BEYAZAL, Münevver vd. "The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine". (2018), 140-145. https://doi.org/10.5152/npa.2016.12691 |
| APA | SERDAROĞLU BEYAZAL M, TÜFEKÇİ A, KIRBAŞ S, TOPALOĞLU M (2018). The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. Nöropsikiyatri Arşivi, 55(2), 140 - 145. 10.5152/npa.2016.12691 |
| Chicago | SERDAROĞLU BEYAZAL Münevver,TÜFEKÇİ AHMET,KIRBAŞ Serkan,TOPALOĞLU MEHMET SERHAT The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. Nöropsikiyatri Arşivi 55, no.2 (2018): 140 - 145. 10.5152/npa.2016.12691 |
| MLA | SERDAROĞLU BEYAZAL Münevver,TÜFEKÇİ AHMET,KIRBAŞ Serkan,TOPALOĞLU MEHMET SERHAT The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. Nöropsikiyatri Arşivi, vol.55, no.2, 2018, ss.140 - 145. 10.5152/npa.2016.12691 |
| AMA | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. Nöropsikiyatri Arşivi. 2018; 55(2): 140 - 145. 10.5152/npa.2016.12691 |
| Vancouver | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine. Nöropsikiyatri Arşivi. 2018; 55(2): 140 - 145. 10.5152/npa.2016.12691 |
| IEEE | SERDAROĞLU BEYAZAL M,TÜFEKÇİ A,KIRBAŞ S,TOPALOĞLU M "The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine." Nöropsikiyatri Arşivi, 55, ss.140 - 145, 2018. 10.5152/npa.2016.12691 |
| ISNAD | SERDAROĞLU BEYAZAL, Münevver vd. "The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine". Nöropsikiyatri Arşivi 55/2 (2018), 140-145. https://doi.org/10.5152/npa.2016.12691 |
